1. Z-Ligustilide Combined with Cisplatin Reduces PLPP1-Mediated Phospholipid Synthesis to Impair Cisplatin Resistance in Lung Cancer
   Pengyu Geng et al, 2023, International Journal of Molecular Sciences CrossRef
2. ACY-241, an HDAC6 inhibitor, overcomes erlotinib resistance in human pancreatic cancer cells by inducing autophagy
   Seong-Jun Park et al, 2021, Archives of Pharmacal Research CrossRef
3. 2-Deoxy-d-Glucose-Induced Metabolic Alteration in Human Oral Squamous SCC15 Cells: Involvement of N-Glycosylation of Axl and Met
   Naeun Lee et al, 2019, Metabolites CrossRef
4. Metabolomic analysis of acerola cherry (Malpighia emarginata) fruit during ripening development via UPLC-Q-TOF and contribution to the antioxidant activity
   Mingfeng Xu et al, 2020, Food Research International CrossRef
5. Multi-omics analysis reveals that ornithine decarboxylase contributes to erlotinib resistance in pancreatic cancer cells
   Won-Jun Jang et al, 2017, Oncotarget CrossRef
6. Metabolic Reprogramming of Chemoresistant Cancer Cells and the Potential Significance of Metabolic Regulation in the Reversal of Cancer Chemoresistance
   Xun Chen et al, 2020, Metabolites CrossRef
7. Thermodynamic Genome-Scale Metabolic Modeling of Metallodrug Resistance in Colorectal Cancer
   Helena A. Herrmann et al, 2021, Cancers CrossRef
8. Exposure to recurrent hypoglycemia alters hippocampal metabolism in treated streptozotocin‐induced diabetic rats
   Neelesh Dewan et al, 2020, CNS Neuroscience & Therapeutics CrossRef